Saturday, November 26, 2016
Intellipharmaceutics submits new drug application for Rexista(oxycodone hydrochloride extended release), an abuse deterrent opioid analgesic for the treatment of moderate to severe pain.
Intellipharmaceutics International - Has identified potential manufacturing partners; currently evaluating manufacturing options for Rexista in U.S.
Source : reuters.com
